Post-Operative Bleed Risks Associated with Perioperative Nonsteroidal Anti-Inflammatory Drugs: A Narrative Review.

IF 1 Q3 ANESTHESIOLOGY
Laura L Seitz, Sanny Juresic, Leslie R Siegel, Nathan T Smith
{"title":"Post-Operative Bleed Risks Associated with Perioperative Nonsteroidal Anti-Inflammatory Drugs: A Narrative Review.","authors":"Laura L Seitz, Sanny Juresic, Leslie R Siegel, Nathan T Smith","doi":"10.1080/15360288.2025.2547839","DOIUrl":null,"url":null,"abstract":"<p><p>Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used medications that function by inhibiting cyclooxygenase enzymes. Although they are highly effective in managing pain and inflammation, their potential for increasing bleeding risks continues to be a concern. Due to the increased risk for bleeding complications following surgical procedures, the safety of perioperative NSAIDs is debated. The primary objective of this article is to examine literature published in the past 10 years focused on post-operative bleeding risks associated with perioperative NSAID use. A systematic search was designed to include randomized controlled trials, systematic review meta-analyses, and retrospective or prospective reviews examining post-operative bleeding events associated with perioperative NSAID use in adults. Following the screening process and review, 11 articles were included. The reviewed literature primarily examines post-operative bleeding incidence, blood loss, hemoglobin decline, and the frequency of hematomas or hemorrhages. Overall, the evidence suggests that perioperative NSAIDs have minimal impact on post-operative bleeding risk. COX-2 selective NSAIDs may be a safer alternative to nonselective NSAIDs, with some studies indicating a lower risk of post-operative bleeding following their use. Ultimately, the decision to use NSAIDs in the perioperative period should be tailored to the specific surgical procedure and individual patient factors.</p>","PeriodicalId":16645,"journal":{"name":"Journal of Pain & Palliative Care Pharmacotherapy","volume":" ","pages":"1-7"},"PeriodicalIF":1.0000,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pain & Palliative Care Pharmacotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15360288.2025.2547839","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used medications that function by inhibiting cyclooxygenase enzymes. Although they are highly effective in managing pain and inflammation, their potential for increasing bleeding risks continues to be a concern. Due to the increased risk for bleeding complications following surgical procedures, the safety of perioperative NSAIDs is debated. The primary objective of this article is to examine literature published in the past 10 years focused on post-operative bleeding risks associated with perioperative NSAID use. A systematic search was designed to include randomized controlled trials, systematic review meta-analyses, and retrospective or prospective reviews examining post-operative bleeding events associated with perioperative NSAID use in adults. Following the screening process and review, 11 articles were included. The reviewed literature primarily examines post-operative bleeding incidence, blood loss, hemoglobin decline, and the frequency of hematomas or hemorrhages. Overall, the evidence suggests that perioperative NSAIDs have minimal impact on post-operative bleeding risk. COX-2 selective NSAIDs may be a safer alternative to nonselective NSAIDs, with some studies indicating a lower risk of post-operative bleeding following their use. Ultimately, the decision to use NSAIDs in the perioperative period should be tailored to the specific surgical procedure and individual patient factors.

围手术期非甾体类抗炎药物与术后出血风险相关的综述。
非甾体抗炎药(NSAIDs)是一种广泛应用的药物,其作用是抑制环加氧酶。尽管它们在控制疼痛和炎症方面非常有效,但它们增加出血风险的可能性仍然令人担忧。由于手术后出血并发症的风险增加,围手术期使用非甾体抗炎药的安全性存在争议。本文的主要目的是回顾过去10年发表的关于围手术期使用非甾体抗炎药的术后出血风险的文献。系统检索包括随机对照试验、系统评价荟萃分析、回顾性或前瞻性评价,检查成人围手术期使用非甾体抗炎药相关的术后出血事件。经过筛选和审查,纳入了11篇文章。所回顾的文献主要检查术后出血发生率、失血、血红蛋白下降和血肿或出血的频率。总的来说,有证据表明围手术期非甾体抗炎药对术后出血风险的影响很小。COX-2选择性非甾体抗炎药可能是一种比非选择性非甾体抗炎药更安全的选择,一些研究表明使用它们后术后出血的风险较低。最终,围手术期使用非甾体抗炎药的决定应根据具体的手术程序和个体患者因素而定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.60
自引率
9.10%
发文量
40
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信